Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

A Novel Biomarker for Inhibitor Risk Prediction-the HLA-II Bound and Unbound Components of FVIII Derived Peptides-Reveals a Protective Influence for N-Linked Glycosylation

Kevin R. Viel, PhD, Marco Hofmann, MD PhD, Sabine Zollner, Bernadette W. Luu, Rajalingam Raja, PhD, Jerry Sherman Powell, MD, Eugene Maraskovsky, MD, PhD, Tom E. Howard, MD PhD

Blood (2015) 126 (23): 2292.

https://doi.org/10.1182/blood.V126.23.2292.2292

Published: 2015

Journal Articles

In Utero Chorionic Villus Stem Cell Transplantation for the Treatment of Hemophilia A

Maricel G Miguelino, MD, Christopher D Pivetti, M.S., Lee Lankford, M.A., Jerry Sherman Powell, MD, Aijun Wang, PhD

Blood (2014) 124 (21): 106.

https://doi.org/10.1182/blood.V124.21.106.106

Published: 2014

Journal Articles

A Prospective, Multi-Center, Randomized Clinical Trial to Compare the Pharmacokinetic Properties of Human-Cl rhFVIII, a New Human-Cell Line Derived Recombinant Factor VIII, with Those of a Full-Length Recombinant Factor VIII Expressed in Baby Hamster Kidney Cells,

Sigurd Knaub, PhD, Andreas Tiede, MD, PhD, Toshko Lissitchkov, MD, PhD, Leonard A. Valentino, MD, FAAP, Jerry Sherman Powell, MD, Marilyn J. Manco-Johnson, MD

Blood (2011) 118 (21): 3309.

https://doi.org/10.1182/blood.V118.21.3309.3309

Published: 2011

Journal Articles

AV513 Promotes Tissue Factor-Mediated Coagulation in Fresh Human Whole Blood from Severe and Moderate Hemophilia a Subjects.

Jerry Sherman Powell, MD, Sabine Knappe, PhD, Janet A Harrison, BS, Susannah Patarroyo-White, BS, Kirk Johnson, PhD, Srinivasa Prasad, PhD

Blood (2008) 112 (11): 1223.

https://doi.org/10.1182/blood.V112.11.1223.1223

Published: 2008

Journal Articles

A New Formulation of Recombinant Human Factor IX Is Bioequivalent to BeneFIX: A Double-Blind, Randomized, Crossover Pharmacokinetic and Open-Label Safety and Efficacy Study.

Jerry Sherman Powell, MD, Thierry Lambert, MD, F. Hernández Navarro, MD, Michael Recht, MD, Sharon T. Sullivan, PhD, Chandrasekhar Udata, PhD, Leslie C. Lilly, BSN, RN, David A. Roth, MD, The rFIX-R Study Group

Blood (2005) 106 (11): 4076.

https://doi.org/10.1182/blood.V106.11.4076.4076

Published: 2005

NARROW

A Novel Biomarker for Inhibitor Risk Prediction-the HLA-II Bound and Unbound Components of FVIII Derived Peptides-Reveals a Protective Influence for N-Linked Glycosylation

In Utero Chorionic Villus Stem Cell Transplantation for the Treatment of Hemophilia A

A Prospective, Multi-Center, Randomized Clinical Trial to Compare the Pharmacokinetic Properties of Human-Cl rhFVIII, a New Human-Cell Line Derived Recombinant Factor VIII, with Those of a Full-Length Recombinant Factor VIII Expressed in Baby Hamster Kidney Cells,

AV513 Promotes Tissue Factor-Mediated Coagulation in Fresh Human Whole Blood from Severe and Moderate Hemophilia a Subjects.

A New Formulation of Recombinant Human Factor IX Is Bioequivalent to BeneFIX: A Double-Blind, Randomized, Crossover Pharmacokinetic and Open-Label Safety and Efficacy Study.

Email alerts

ASH Publications

American Society of Hematology

A Novel Biomarker for Inhibitor Risk Prediction-the HLA-II Bound and Unbound Components of FVIII Derived Peptides-Reveals a Protective Influence for N-Linked Glycosylation

In Utero Chorionic Villus Stem Cell Transplantation for the Treatment of Hemophilia A

A Prospective, Multi-Center, Randomized Clinical Trial to Compare the Pharmacokinetic Properties of Human-Cl rhFVIII, a New Human-Cell Line Derived Recombinant Factor VIII, with Those of a Full-Length Recombinant Factor VIII Expressed in Baby Hamster Kidney Cells,

AV513 Promotes Tissue Factor-Mediated Coagulation in Fresh Human Whole Blood from Severe and Moderate Hemophilia a Subjects.

A New Formulation of Recombinant Human Factor IX Is Bioequivalent to BeneFIX: A Double-Blind, Randomized, Crossover Pharmacokinetic and Open-Label Safety and Efficacy Study.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only